Citra Nusantara Gemilang Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Citra Nusantara Gemilang Tbk. trades at Rp149 (market cap 267.5B, 1.18M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,780 (market cap 12.58T, 235.2K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 47× Citra Nusantara Gemilang Tbk.'s market cap, and Citra Nusantara Gemilang Tbk. is more actively traded (1.18M versus 235.2K). Which is the better fit depends on your goals.
| CGAS | TSPC | |
|---|---|---|
Market Cap | 267.5B | 12.58T |
Volume | 1.18M | 235.2K |
Lot | 11.84K | 2.35K |
Turnover | 177.38M | 649.94M |
Average Price | 149.88 | 2,763.37 |
Value | 177.38M | 649.94M |
Indicative Equilibrium Price | 149 | 2,780 |
Indicative Equilibrium Volume | 432 | 9 |
Trailing returns across standard periods
Latest headlines on both assets
PT Citra Nusantara Gemilang Tbk (the “Company”), was established based on Notarial Deed No. 22, dated December 21, 2005 of Edi Priyono, S.H.. The Company's parent entity is PT Petro Asia Energy
Read more on CGAS →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →